![]() |
市場調查報告書
商品編碼
1626553
脫髮治療產品市場:依產品類型、通路和地區,2024年至2031年Hair Loss Treatment Products Market By Product Type (Shampoo & Conditioner, Oil, Serum), Distribution Channel (Supermarkets and Hypermarkets, Convenience Stores, Specialty Retailers, Pharmacies, Online Retail), & Region for 2024-2031 |
壓力的增加、不良的飲食習慣、荷爾蒙失衡以及男性禿頭的增加都導致了市場的成長。消費者越來越注重自己的外表和美麗。隨著男性和女性越來越重視年輕化以及尋求解決頭髮稀疏和禿頭的有效解決方案,預計到2024年市場規模將達到 234億美元,到2031年將達到 634億美元。
雷射治療和生髮精華等技術的進步以及非處方產品的日益普及推動市場擴張。此外,隨著社群媒體和名人對護髮產品的代言推動了消費者興趣的增加,脫髮治療全球轉變為一個蓬勃發展的行業,從2024年到2031年的年複合成長率約為 13.26%。
脫髮治療產品市場:定義/概述
脫髮治療產品包括藥物、局部治療、洗髮精、精華液、小工具等,目的是減緩、預防或逆轉頭髮稀疏或禿頭。這些產品通常用於治療雄性禿、荷爾蒙性脫髮和環境性脫髮。它因其用途而受到男性和女性的歡迎:促進頭髮生長,強化現有頭髮,並防止進一步脫髮。由於生物技術的進步、個人化治療以及客戶對非侵入性手術的需求不斷增加,市場前景看好。預計幹細胞療法和促進毛髮生長配方等創新技術將在未來幾年推動市場成長。
脫髮治療市場中的全球雷射治療部分迅速擴張,基於雷射的解決方案作為一種非侵入性治療選擇越來越受歡迎。根據2024年 2月的Market Watch 資料,雷射治療市場預計將在2023年創造 31億美元的收入,到2028年的年複合成長率為 15.6%。2024年1月,FDA核准了升級版家用雷射治療設備,消費者接受度提升了92%。2024年 3月發表在 "International Journal of Trichology" 上的一項最新臨床試驗發現,低強度雷射療法(LLLT)在六個月內成功使 85%的參與者的頭髮重新長出來,並且該治療對 25 至 45 歲之間的患者尤其有效。
2023年 12月,Philips計劃推出一款突破性的人工智慧雷射治療帽,臨床試驗證明,該治療帽可以使頭髮密度提高 67%。全球雷射設備領導者HairMax於2024年2月宣布,已與中國醫療保健公司BeiGene建立戰略合作夥伴關係,以1.5億美元的投資為後盾,在亞洲範圍內提供最新的激光帶技術。2024年3月,歐洲藥品管理局(EMA)批准了一種將雷射治療與生長因子結合的新型聯合療法;2024年4月,澳洲政府撥出7,500萬澳元用於研究增強雷射技術用於頭髮再生。此外,Venus Concept於2024年3月發布的季報顯示,雷射設備銷量較去年同期成長178%,顯示消費市場擴張。
產品成本高且性能不穩定可能會嚴重阻礙掉髮治療產品市場的擴張。許多治療方法都很昂貴,尤其是那些需要處方或包括幹細胞療法等先進程序的治療方法。這可能會限制其獲得更大的消費者群體的機會,尤其是在可支配收入較低的新興國家。此外,持續治療帶來的經濟負擔可能會阻止患者全力接受治療,導致市場需求減少。例如,一些消費者可能願意為成功的脫髮治療付費,但結果的不確定性可能會使他們對支出持謹慎態度,特別是如果他們以前對無效的產品感到失望。
此外,脫髮治療效果的差異可能會導致消費者的不信任和不滿。市面上許多的藥物,包括米諾地爾和非那雄胺等局部治療藥物,都不能保證對每個人都有效,導致使用體驗各不相同。目前尚無針對所有類型脫髮的通用治療方法,而且遺傳、荷爾蒙和生活方式等變數都會影響個別治療的效果,使問題更加複雜。這種差異會削弱市場信心,迫使潛在客戶尋求替代療法或完全避免治療。因此,生產商面臨的挑戰不僅在於生產好的產品,還在於在消費者中建立聲譽和信任。
Increasing stress, poor diet, hormonal imbalances, and an increase in occurrences of androgenetic alopecia are all contributing to the market's growth. Consumers are becoming more conscious of their personal grooming and aesthetics. With a greater emphasis on young appearance, both men and women are looking for effective ways to counteract hair thinning and balding is fuelling the USD 23.4 Billion in 2024 and reaching USD 63.4 Billion by 2031.
Technological improvements such as laser therapy and hair growth serums, together with increased availability of over-the-counter products, are driving market expansion. Furthermore, the influence of social media and celebrity endorsements of hair care products has raised consumer interest, transforming hair loss therapy into a thriving sector globally is grow at a CAGR of about 13.26% from 2024 to 2031.
Hair Loss Treatment Products Market: Definition/ Overview
Hair loss therapy goods include drugs, topical treatments, shampoos, serums, and gadgets that aim to delay, prevent, or reverse hair thinning and balding. These products are often used to treat androgenetic alopecia, hormonal hair loss, and environmental hair damage. Applications include increasing hair regrowth, strengthening existing hair, and preventing further hair loss, and are popular with both men and women. This market's future looks good, owing to advances in biotechnology, individualized treatments, and rising customer demand for non-invasive remedies. Innovations such as stem cell therapy and enhanced hair growth formulas are projected to fuel future market growth.
The global laser therapy segment of the hair loss treatment market is rapidly expanding, with laser-based solutions emerging as a popular non-invasive treatment option. According to Market Watch data from February 2024, the laser therapy market generated USD 3.1 Billion in 2023 and is expected to rise at a CAGR of 15.6% through 2028. In January 2024, the FDA approved upgraded at-home laser therapy equipment, which resulted in a 92% rise in consumer acceptance rates. In March 2024 Recent clinical trials published in the International Journal of Trichology found that low-level laser therapy (LLLT) resulted in successful hair regeneration in 85% of participants over a six-month period, with particular efficacy among patients aged 25-45.
Philips will released their groundbreaking AI-powered laser therapy hat in December 2023, with clinical testing showing a 67% improvement in hair density. HairMax, a world leader in laser devices, announced in February 2024 a strategic alliance with Chinese healthcare company BeiGene to deliver its latest laser band technology throughout Asia, backed by a USD 150 Million investment. In March 2024, the European Medicines Agency (EMA) approved a new combination therapy combining laser treatment with growth factors, while in April 2024 the Australian government set aside AUD 75 million for research into enhanced laser technology for hair restoration. Furthermore, Venus Concept's quarterly report in March 2024 disclosed a 178% rise in laser device sales compared to the previous year, demonstrating the expanding consumer
High product costs and uneven performance can seriously impede the expansion of the hair loss treatment products market. Many treatments, particularly those requiring a prescription or involving advanced therapies such as stem cell treatments, are expensive. This can limit access to a larger consumer base, especially in emerging economies with smaller disposable expenditures. Furthermore, the financial burden involved with continued therapies may prevent customers from pursuing remedies entirely, resulting in lower market demand. For example, while some consumers may be prepared to pay in successful hair loss solutions, uncertainty about the results may lead to caution in spending, especially for those who have previously encountered disappointment with less effective items.
Furthermore, the uneven efficacy of hair loss therapies might lead to consumer distrust and unhappiness. Many medicines on the market, including topical therapies like as minoxidil and finasteride, may not guarantee results for everyone, resulting in diverse user experiences. The lack of a common remedy for all types of hair loss complicates matters further, as individual therapy responses can vary depending on genetic, hormonal, and lifestyle variables. This discrepancy may lead to a loss of trust in the market, forcing potential clients to seek alternate cures or avoid therapy entirely. As a result, producers confront the problem of not only manufacturing good products but also building reputation and confidence among consumers.
Shampoos and conditioners are widely used in regular hair care routines, which might greatly boost the market for hair loss treatment solutions. As people become more aware of the importance of scalp health and hair maintenance, they are incorporating specialist hair care products that address hair loss into their regular routines. For example, manufacturers like as Nioxin and Kerastase are introducing shampoos and conditioners that are particularly designed to strengthen hair and stimulate growth while also addressing thinning hair concerns. In May 2024 L'Oreal launched plant-based hair care products to improve scalp health and meet the growing demand for eco-friendly choices. This emphasis on preventive care is causing more people to seek items that not only clean and condition hair but also contribute to overall hair health.
In April 2024, the FDA announced its support for clinical research on new formulations that combine traditional hair care products with active hair restoration chemicals, with the goal of increasing their effectiveness. This regulatory backing is anticipated to increase consumer trust in using these products on a regular basis, as they are intended not only for cosmetic appeal but also for genuine hair growth benefits.
However, the serum segment is the fastest expanding, owing to increased demand for focused therapies with greater efficacy and faster outcomes. Hair growth serums, which are frequently loaded with modern compounds such as peptides and minoxidil, are gaining popularity among consumers looking for more effective, non-invasive treatments for hair thinning and regrowth.
Rising sales through pharmacies are expected to greatly boost the hair loss treatment products industry. Pharmacies are increasingly becoming favored distribution channels for hair loss treatments due to their accessibility and consumers' trust in them for health-care items. The simplicity of purchasing hair loss remedies alongside other personal care items appeals to consumers looking for discreet and uncomplicated answers to their hair problems. Recent agreements between pharmaceutical firms and retail chains aim to increase the availability of popular therapies such as minoxidil and finasteride, allowing consumers to obtain effective remedies more easily. For instance, in June 2024, Walgreens announced a collaboration with numerous producers to ensure that popular hair loss remedies are more prominently advertised in their shops, thus catering to rising consumer demand.
In February 2024, the United States Department of Health initiated a campaign to educate the public on hair health, including the availability of treatments at local pharmacies. This campaign is aimed to raise awareness and encourage customers to seek out drugstore remedies for hair loss. With pharmacies serving as trustworthy sources of health information, this effort attempts to increase consumer confidence in purchasing hair loss remedies.
However, the fastest expanding area is online retail, which is driven by the convenience of home delivery, a larger selection of product offerings, and rising consumer preference for e-commerce platforms. Discounts, user reviews, and focused marketing all help online shops by attracting tech-savvy consumers looking for individualized hair loss solutions.
Country/Region-wise
The North American hair loss treatment products market is expanding rapidly, driven by rising demand for aesthetic treatments and increased awareness of innovative hair restoration options. According to latest market research data from March 2024, the market value hit USD 4.2 Billion in 2023 and is expected to increase at a CAGR of 9.8% between 2024 and 2028. This increase is most obvious in the United States, where roughly 50 million men and 30 million women suffer from hair loss, with 66% of males experiencing visible hair loss by the age of 35, according to the American Hair Loss Association's January 2024 report.
In August 2023, Johnson & Johnson's announced of their improved topical hair growth solution, which had an 85% success rate in clinical trials, and Merck received FDA clearance in February 2024 for a novel oral therapy for androgenetic alopecia. Additionally, in September 2023, the Canadian government announced a USD 50 Million investment in research funding for hair restoration technologies, with an emphasis on stem cell therapy and individualized treatment options. The advent of telemedicine services has also aided market growth, with companies such as Hims & Hers reporting a 120% increase in hair loss consultations in Q4 2023 over the previous year.
The Asia Pacific hair loss treatment products market is experiencing unprecedented expansion, driven by rising beauty consciousness and rising disposable income across the region. According to a Verified Market Research published the hair care market is predicted to rise at a CAGR of 5.60% to USD 129.63 Billion by 2031, from USD 83.83 Billion in 2023. China leads this expansion, accounting for 34% of the market, followed by Japan and South Korea. According to the Asian Dermatological Association's March 2024 report, 42% of men and 25% of women in metropolitan Asian areas suffer from premature hair loss, with a 73% increase in treatment-seeking behavior among people aged 25-40 over the last two years.
In February 2024, the Japanese government announced a historic USD 200 Million effort to promote research and development in hair restoration technology, while Singapore's Health Sciences Authority (HSA) gave fast-track approval status to three innovative hair loss therapies in March 2024. Alibaba, the Chinese e-commerce giant, reported that hair loss treatment product sales increased by 156% year on year during the 2024 Lunar New Year shopping festival, while Indian pharmaceutical company Sun Pharma announced in April 2024 that it would expand its hair care portfolio by acquiring a Korean hair technology startup for USD 180 Million.
The competitive landscape of the Hair Loss Treatment Products Market is characterized by the presence of various players offering a range of solutions, including prescription medications, over-the-counter treatments, and natural or herbal remedies. The market is increasingly driven by innovation, with companies focusing on developing new, advanced formulations like low-level laser therapy (LLLT) devices and stem cell treatments. Consumer preference for non-invasive and natural solutions is also shaping the market. Additionally, the rise of e-commerce platforms has intensified competition, as brands target a global audience through online sales channels, offering customized treatment plans and subscription-based services.
Some of the prominent players operating in the hair loss treatment products market Include:
L'Oreal
Unilever
Taisho
Henkel
Merck
Shiseido
Johnson & Johnson Consumer, Inc.
Rohto
Lifes2Good
Gerolymatos International
Toppik
Nanogen
Oxford BioLabs Ltd.
Ultrax Labs
Avalon Natural Products
Bayer
Pharma Medico
Kirkland Signature
Phyto Ales Group
Amplixin
Kerafiber
Keranique
DS Healthcare Group
Kaminomoto
Softto
Bawang
In July 2024, L'Oreal has launched a new plant-based, eco-friendly hair serum as part of its sustainability effort. The serum, which is part of the Kerastase line, targets early-stage hair thinning and is likely to appeal to environmentally aware consumers.
In June 2024, RepliCel announced development in its dermal sheath cup cell treatment for hair restoration. Early clinical data suggest enhanced hair follicle regeneration, and expanded trials are scheduled for late 2024.
Unilever
Taisho
Henkel
Merck
Shiseido
Johnson & Johnson Consumer, Inc.
Rohto
Lifes2Good
Gerolymatos International
Toppik
Nanogen
Oxford BioLabs Ltd.
Ultrax Labs
Avalon Natural Products
Bayer
Pharma Medico
Kirkland Signature
Phyto Ales Group
Amplixin
Kerafiber
Keranique
DS Healthcare Group
Kaminomoto
Softto
Bawang